B·R·A·H·M·S Prenatal Screening Solutions

Discover the power of prenatal screening on KRYPTOR 

Are you looking for a complete solution to enhance your prenatal screening capabilities? Look no further. Our comprehensive offering, which includes Thermo Scientific B·R·A·H·M·S biomarkers, Thermo Scientific B·R·A·H·M·S KRYPTOR Instruments, and Thermo Scientific B·R·A·H·M·S Fast Screen Software, is tailored to meet the needs of clinicians and laboratory managers like you.

Fetal aneuploidy and neural tube defects

B·R·A·H·M·S Prenatal Screening solutions for trisomy and neural tube defects screening in first and second trimester.

Pre-eclampsia management

B·R·A·H·M·S Prenatal Screening solutions for improved pre-eclampsia management from the first to third trimester of pregnancy.

KRYPTOR analyzers

B·R·A·H·M·S Prenatal Screening Assays are designed to run on B·R·A·H·M·S KRYPTOR Instruments, fully automated random access immunoanalyzers utilizing Nobel Prize winning TRACE technology.

Improve prenatal care for mothers and babies

Birth defects affect approximately 6% of babies worldwide1, highlighting the critical need for effective screening methods. Additionally, pre-eclampsia, a pregnancy complication characterized by hypertension, poses significant risks to both mother and baby. With a prevalence of 2-4% in all pregnancies, pre-eclampsia remains a leading cause of maternal and fetal mortality and morbidity.2

Serum biomarkers play a pivotal role in early identification of pregnancies at risk for fetal aneuploidies, fetal neural tube defects, and maternal pre-eclampsia. By providing clinicians and laboratory managers with accurate and reliable risk assessment tools, we aim to improve the management and outcomes of these high-risk pregnancies. Our products enable early intervention, allowing for timely medical interventions and personalized care plans.

Explore our complete biomarker porfolio

Benefit from the power of prenatal screening on KRYPTOR

  • Complete biomarker portfolio for trisomy and pre-eclampsia management
  • Precise and stable results with B·R·A·H·M·S Assays
  • B·R·A·H·M·S KRYPTOR Instruments for optimal lab routine
  • Powerful and robust clinical risk software

Explore our complete biomarker portfolio

Our B·R·A·H·M·S Biomarkers offer a wide range of options to cover multiple screening strategies throughout pregnancy. With our solution, you have the flexibility to choose the most suitable biomarkers for your specific screening needs. By utilizing just one instrument, you can streamline your workflow and optimize efficiency in your laboratory.

Not all products have FDA clearance for sale in the US.

Trust your results with our B·R·A·H·M·S Prenatal Screening solution

We understand the importance of accurate results in prenatal screening. Our B·R·A·H·M·S KRYPTOR Instruments utilize advanced TRACE technology to deliver reliable and precise measurements, minimizing interference and ensuring the highest level of confidence in your patients' results.

 

With our biotin-free technology, you can reduce the risk of errors due to interferences and confidently interpret the screening outcomes. Our B·R·A·H·M·S Biomarkers offer outstanding long-term lot-to-lot stability and high precision.3

 

Not only are our solutions effective, but they are also fully compliant with the new In Vitro Diagnostic Regulation (IVDR) and are approved by the Fetal Medicine Foundation (FMF). Our B·R·A·H·M·S PlGF plus KRYPTOR and B·R·A·H·M·S sFlt-1 KRYPTOR assays are the first to receive FDA approval for the risk assessment of pre-eclampsia with severe features within 2 weeks of presentation.

 

This guarantees that our products meet the strictest quality and safety standards, allowing you to focus on delivering the best possible care to your patients.

 

Get support from the experts

With 25 years of expertise in the field, we have a deep understanding of the complexities involved in prenatal screening and recognize the importance of having access to expert support in your daily practice.

 

Our dedicated team of experts is providing you with the guidance and assistance you need. From implementation to troubleshooting, we are here to ensure that you have a smooth and successful experience with our solution.

 

Choose the power of prenatal screening on KRYPTOR and unlock the full potential of your practice. Experience the confidence that comes with our complete solution, backed by years of expertise and unwavering commitment to delivering excellence in prenatal care.

Featured resources

Related pages

References

  1. World Health Organization. (n.d.). Congenital disorders. World Health Organization. https://www.who.int/health-topics/congenital-anomalies 
  2. Magee LA et al. NEJM 2022;386:1817-32
  3. UK Neqas reports

Thermo Fisher Scientific products are distributed globally and their uses, applications, indications, claims and availability of products in each country depend on local regulatory marketing authorization status, please consult the Instructions For Use (IFU) available in your country.

 

© 2024 Thermo Fisher Scientific Inc. All rights reserved. All trademarks are the property of Thermo Fisher Scientific and its subsidiaries unless otherwise specified. B·R·A·H·M·S is a registered trademark of B·R·A·H·M·S GmbH.

 

KRYPTOR and TRACE are trademarks of Cisbio Bioassays, licensed for use by B·R·A·H·M·S GmbH, a part of Thermo Fisher Scientific. Nobel Prize is a registered trademark of the Nobel Foundation.